論文業績2012年

Home>論文業績>論文業績2012
1. Onishi I, Paulo J.C.Lin, Numata Y, Pamela Austi, Jane Cipollone, Michel Roberge, Calvin D.Roskeller, Numata M.: Organellar (Na+, K+)/H+ exchanger NHE7 regulates cell adhesion, invasion and anchorage-independent growth of breast cancer MDA-MB-231 cells. Oncology Reports 27(2):311-317,2012.02
2. Hayashi H, Takamura H, Yamaguchi Y, Shiji Y, Nakagawara H, tajima H, Onishi I, Kitagawa H, Tani T, Kayahara M, Ohta T.:Recent role of Hassab's operation for cirrhotic patients: Combination with endoscopic procedure for varices. Asian Journal of Surgery 35(2):57-61, 2012.04
3. Tajima H, Ohta T, Kitagawa H, Okamoto K, Sakai S, Kinoshita J, Makino I, Furukawa H, Hayashi H, Nakamura K, Oyama K, Inokuchi M, Nakagawara H, Fujita H, Takamura H, Ninomiya I, Fushida S, Tani T, Fujimura T, Kitamura S, Ikeda H, Tsuneyama K.:Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44. Oncology Letters 3(6):1186-1190,2012.06
4. Hayashi H, Takamura H, Tani T, Makino I, Nakagawara H, Tajima H, Kitagawa H, Onishi I, Shimizu K, Ohta T.: Partial portal arterialization for hepatic arterial thrombosis after living-donor liver transplant. Experimental and Clinical Transplntation 10(3):247-251, 2012.06
5. Fujimura T, Kinoshita J, Makino I, nakamura K, Oyama K, Fujita H, Tajima H, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Ohta T, Miwa K.: Gastric cancer -state of the art in Japan. Rozhledy v chirurgii 91(6):346-352, 2012.06(Epub ahead of print)
6. Oyama K, Fushida S, Kinoshita J, Okamoto K, Makino I, Nakamura K, Hayashi H, Inokuchi M, Nakagawara H, Tajima H, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Fujimura T, Ohta T.: Serum cytokeratin 18 as a biomarker for gastric cancer. Clinica and Experimental Medicine 2012.07(Epub ahead of print)
7. Tsukada T, Fushida S, Harada S, Yagi Y, Kinoshita J, Oyama K, Tajima H, Fujita H, Ninomiya I, Fujimura T, Ohta T.: The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer. Int J Oncol 41(2):476-482, 2012.08
8. Okamoto K, Tajima H, Nakanuma S, Sakai S, Makino I, Kinoshita J, Hayashi H, Nakamura K, Oyama K, Nakagawara H, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Fujumura T, Harada S, Wakayama T, Iseki S, Ohta T.: Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma. Int J Oncol. 41(2):573-582, 2012.08
9. Kong D, Piao YS, Yamashita S, Oshima H, Oguma K, Fushida S, Fujimura T, Minamoto T, Seno H, Yamada Y, Satou K, Ushijima T, Ishikawa TO, Oshima M.: Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells. Oncogene 31(35): 3949-3960, 2012.08
10. Onishi I, Kayahara M, Munemoto M, Sasaki S, Makino I, Hayashi H, Nakagawara Hm Tajima H, Takamura H, Kitagawa H, Tani T, Ohta T.: Management of postoperative hemorrhage associated with factor Ⅷinhibitor: report of a case. Surg Today 2012.08(Epub ahead of print)
11. Tsukada T, Nakano T, Miyata T, Sasaki S, Ohta T.: Cholecystomucoclasis: revaluation of safety and validity in aged populations. BMC Gastroenterology 12:113, 2012
12. Ninomiya I, Nagai N, Oyama K, Hayashi H, Tajima H, Kitagawa H, Fushida S, Fujimura T,Ohta T.: Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum. Oncology Reports 28(3):777-782, 2012.09
13. Yoshimoto K, Tajima H, Ohta T, Okamoto K, Sakai S, Kinoshita J, Furukawa H, Makino I, Hayashi H, Kanamura K, Oyama K, Inokuchi M, Nakagawara H, Itoh H, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Wakayama T, Iseki S, Shimizu K.: Increased E-selection in hepatic ischemia-reperfusion injury mediates liver metastasis of pancreatic cancer. Oncology Reports 28(3):791-796, 2012.09
14. Miyashita T, Miwa K, Fujimura T, Ninomiya I, Fushida S, Shah F, Harmon J, Hattori T, Ohta T.: The severity of duodeno-esophageal reflux infiuences the development of different histological types of esophageal cancer in a rat model. International Journal of Cancer 2012.09(Epub ahead of print)
15. Makino I, Kitagawa H, Nakagawara H, tajima H, Ninomiya I, Fushida S, Fujimura T, Ohta T.:The management of a remnant pancreatic stump for preventing the development of postoperative pancreatic fistulas after distal pancreatectomy: current evidence and our strategy. Surgery Today 2012.10(Epub ahead of print)
16. Miyashita T, Shah FA, Harmon JW, Marti GP, Matsui D, Okamoto K, Makino I, Hayashi H, Oyama K, Nakagawara H, Tajima H, Fujita H, Takamura H, Murakami M, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Ohta T.: Do proton pump inhibitors protect against cancer progression in GERD?. Surgery Today 2012.10.31(Epub ahead of print)
17. Yamashita T, Honda M, Nakamoto Y, Baba M, Nio K, Zeng SS, Hayashi T, Kondo M, Takatori H, Yamashita T, Mizukoshi E, Zen Y, Takamura H, Wang XW, Kaneko S.: Discrete nature of EpCAM(+) and CD90(+) cancer cells in human hepatocellular carcinoma. Hepatology 2012.11(Epub ahead of print)
18. Tajima H, Ohta T, Shinbashi H, Hirose A, Tsukada T, Okamoto K, Nakanuma S, Sakai S, Furukawa H, Makino I, Nakamura K, Hayashi H, Oyama K, Inokuchi M, Nakagawara H, Miyashita T, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Mouri H.: Successful treatment of unresectable gallbladder cancer with low-dose paclitaxel as palliative chemotherapy after failure of gemcitabine and oral S-1:A case report. Oncology Letters 4(6):1281-1284,2012.12
19. Miyashita T, Shah F, Miwa K, Sasaki S, Nishijima K, Oyama K, Ninomiya I, Fushida S, Fujimura T, Hattori T, Harmon J, Ohta T.: Impact of inflammation-metaplasia- adenocaarcinoma sequence and prevention in surgecal rat models. Digestion 87(1): 6-11, 2013.01
20. Oyama K, Fushida S, Kaji M, Takeda T, Kinami S, Hirono Y, Yoshimoto K, Yabushita K, Hirosawa H, Takai Y, Nakano T, Kimura H, Yasui T, Tsuneda A, Tsukara T, Kinoshita J, Fujimura T, Ohta T. Aprepitant plus granisetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer trated with S-1 plus cisplatin. J Gastroenterol. 2013.01.22(Epub ahead of print)
21. Tsukada T, Fushida S, Harada S, Terai S, Yagi Y, Kinoshita J, Oyama K, Tajima H, Nimomiya I, Fujimura T, Ohta T.: Low-dose paclitaxel modulates tumor fibrosis in gastric cancer. Int J Oncology 2013.01(Epub ahead of print)
22. Fushida S, Kinoshita J, Kaji M, Hirono Y, Goda F, Yagi Y, Oyama K, Sudo Y, Watanabe Y, Fujimura T;Society for the Study of Peritoneal Carcinomatosis in Gastric Cancer. Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis. Cancer Chemother Pharmacol. 2013.02.20(Epub ahead of print)
23. Kitagawa H, Tajima H, Nakagawara H, Hayashi H, Makin I, Takamura H, Ninomiya I, Fushida S, Kayahara M, Ohta T, Ikeda H.: The reetropancreatic fusion fascia acts as a barrier against infiltration by pancreatic carcinoma. Molecular and Clinical Oncology 1(3):418-422, 2013.0.3(Epub ahead of print)